It has been a great honor to be a part of President Biden’s Cancer Moonshot delegation to India and to participate in the US-India Cancer Dialogue Initiative.

It was heartening to see scientists, researchers, clinicians, industry professionals, patient advocates, and governments from both sides come together to share perspectives in areas of:

• AI enabled Innovation for Cancer Care
• Novel Therapeutics – Vaccines, Immunotherapy, and other Biologicals
• Cancer Genomics and Precision Medicine
• Cost Effective Equitable Cancer Therapy and Implementation Science
• Cancer Clinical Trials: Priorities, Regulatory Landscape& Capacity Building
• Holistic Survivorship Care
• Common Molecular links underlying Cancer, CVDs/NCDs –Role of Complementary & Alternative Medicines

Dr. Krishnan made a presentation under “Cost Effective Equitable Cancer Therapy and Implementation Science” highlighting the burden of cervical cancer despite it being an almost completely preventable disease, with HPV vaccination, screening and early treatment that could be administered even in remote parts of the developing world.

We hope the invigorating discussions around challenges and possible solutions will mark the beginning of a renewed commitment by both countries to collaborate and achieve our first “win” over cancer.

Interview with the Press Trust of India: Deccan Herald Interview.

This article was first published on GIAHC’s website and can be found here.